All terms in GO
| Label | Id | Description |
|---|---|---|
| prephenate(2-) metabolic process | GO_1901745 | [The chemical reactions and pathways involving prephenate(2-).] |
| prephenate(2-) catabolic process | GO_1901746 | [The chemical reactions and pathways resulting in the breakdown of prephenate(2-).] |
| beta1-adrenergic receptor activity | GO_0004940 | [Combining with epinephrine or norepinephrine to initiate a change in cell activity via activation of a G protein, with pharmacological characteristics of beta1-adrenergic receptors.] |
| beta-adrenergic receptor activity | GO_0004939 | [Combining with epinephrine or norepinephrine to initiate a change in cell activity via activation of a G protein, with pharmacological characteristics of beta-adrenergic receptors; the activity involves transmitting the signal to the Gs alpha subunit of a heterotrimeric G protein.] |
| prephenate(2-) biosynthetic process | GO_1901747 | [The chemical reactions and pathways resulting in the formation of prephenate(2-).] |
| beta2-adrenergic receptor activity | GO_0004941 | [Combining with epinephrine or norepinephrine to initiate a change in cell activity via activation of a G protein, with pharmacological characteristics of beta2-adrenergic receptors.] |
| leukotriene D4 metabolic process | GO_1901748 | [The chemical reactions and pathways involving leukotriene D4.] |
| GO_0004942 | GO_0004942 | |
| leukotriene D4 catabolic process | GO_1901749 | [The chemical reactions and pathways resulting in the breakdown of leukotriene D4.] |
| leukotriene catabolic process | GO_0036100 | [The chemical reactions and pathways resulting in the breakdown of a leukotriene, a pharmacologically active substance derived from a polyunsaturated fatty acid, such as arachidonic acid.] |
| GO_0004943 | GO_0004943 | |
| GO_0004944 | GO_0004944 | |
| angiotensin type II receptor activity | GO_0004945 | [An angiotensin receptor activity that acts via Gi protein coupling and cGMP (NO) generation, and may also act via additional signaling mechanisms.] |
| angiotensin receptor activity | GO_0001595 | [Combining with angiotensin to initiate a change in cell activity.] |
| bombesin receptor activity | GO_0004946 | [Combining with bombesin to initiate a change in cell activity.] |
| neuropeptide receptor activity | GO_0008188 | [Combining with a neuropeptide to initiate a change in cell activity.] |
| bombesin receptor signaling pathway | GO_0031989 | [The series of molecular signals generated as a consequence of a bombesin receptor binding to one of its physiological ligands.] |
| bradykinin receptor activity | GO_0004947 | [Combining with bradykinin to initiate a change in cell activity.] |
| calcitonin receptor activity | GO_0004948 | [Combining with calcitonin and transmitting the signal across the membrane by activating an associated G-protein; promotes the exchange of GDP for GTP on the alpha subunit of a heterotrimeric G-protein complex.] |
| calcitonin binding | GO_0032841 | [Interacting selectively and non-covalently with calcitonin, a peptide hormone responsible for reducing serum calcium levels by inhibiting osteoclastic bone reabsorption and promoting renal calcium excretion. It is synthesized and released by the C cells of the thyroid.] |